WallStreetZenWallStreetZen

NASDAQ: CYCC
Cyclacel Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for CYCC

Based on 1 analyst offering 12 month price targets for Cyclacel Pharmaceuticals Inc.
Min Forecast
$11.00+447.26%
Avg Forecast
$11.00+447.26%
Max Forecast
$11.00+447.26%

Should I buy or sell CYCC stock?

Based on 1 analyst offering ratings for Cyclacel Pharmaceuticals Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CYCC stock forecasts and price targets.

CYCC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-03

1 of 1

Forecast return on equity

Is CYCC forecast to generate an efficient return?

Forecast return on assets

Is CYCC forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CYCC revenue forecast

What is CYCC's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$56.0M+12,369.93%
Avg 2 year Forecast
$115.1M+25,528.06%
Avg 3 year Forecast
$160.1M+35,563.7%
CYCC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CYCC revenue growth forecast

How is CYCC forecast to perform vs Biotechnology companies and vs the US market?
Company
612.59%
Industry
35.65%
Market
10.58%
CYCC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CYCC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CYCC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CYCC$2.01$11.00+447.26%Strong Buy
APVO$0.73N/AN/A
QNRX$0.72$4.00+455.56%Strong Buy
SEEL$1.39N/AN/A
REVB$1.73N/AN/A

Cyclacel Pharmaceuticals Stock Forecast FAQ

Is Cyclacel Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: CYCC) stock is to Strong Buy CYCC stock.

Out of 1 analyst, 1 (100%) are recommending CYCC as a Strong Buy, 0 (0%) are recommending CYCC as a Buy, 0 (0%) are recommending CYCC as a Hold, 0 (0%) are recommending CYCC as a Sell, and 0 (0%) are recommending CYCC as a Strong Sell.

If you're new to stock investing, here's how to buy Cyclacel Pharmaceuticals stock.

What is CYCC's revenue growth forecast for 2026-2028?

(NASDAQ: CYCC) Cyclacel Pharmaceuticals's forecast annual revenue growth rate of 612.59% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.65%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.58%.

Cyclacel Pharmaceuticals's revenue in 2024 is $449,000.On average, 1 Wall Street analysts forecast CYCC's revenue for 2026 to be $81,927,871, with the lowest CYCC revenue forecast at $81,927,871, and the highest CYCC revenue forecast at $81,927,871. On average, 1 Wall Street analysts forecast CYCC's revenue for 2027 to be $168,377,213, with the lowest CYCC revenue forecast at $168,377,213, and the highest CYCC revenue forecast at $168,377,213.

In 2028, CYCC is forecast to generate $234,311,664 in revenue, with the lowest revenue forecast at $234,311,664 and the highest revenue forecast at $234,311,664.

What is CYCC's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CYCC) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CYCC's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CYCC price target, the average CYCC price target is $11.00, with the highest CYCC stock price forecast at $11.00 and the lowest CYCC stock price forecast at $11.00.

The Wall Street analyst predicted that Cyclacel Pharmaceuticals's share price could reach $11.00 by May 3, 2025. The average Cyclacel Pharmaceuticals stock price prediction forecasts a potential upside of 447.26% from the current CYCC share price of $2.01.

What is CYCC's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CYCC) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.